Patent details

Basic Information

Publication number:

EP2460520

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP121522825

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy

French Title of Invention:

Procédés de dosage de 1,2,4-oxadiazole oralement active pour thérapie de suppression de mutation non-sens

German Title of Invention:

Verfahren zur Dosierung eines oral aktiven 1,2,4-Oxadiazols für Therapien zur Unterdrückung von Nonsense-Mutationen

SPC Number:

Dates

Filing date:

11/10/2007

Grant date:

30/09/2015

EP Publication Date:

30/09/2015

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/06/2012

EP B1 Publication Date:

30/09/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/10/2015

Expiration date:

11/10/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/10/2007

 

 

Name:

PTC Therapeutics Inc.

Address:

100 Corporate Court, Middlesex Business Center, South Plainfield, NJ 07080, United States (US)

Inventor

1

Name:

Miller Langdon

Address:

United States (US)

2

Name:

Hirawat Samit

Address:

United States (US)

Priority

Priority Number:

851450 P

Priority Date:

12/10/2006

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/4245;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages